JP2009513529A - ステアリン酸マグネシウムを含む医薬製剤 - Google Patents

ステアリン酸マグネシウムを含む医薬製剤 Download PDF

Info

Publication number
JP2009513529A
JP2009513529A JP2006518169A JP2006518169A JP2009513529A JP 2009513529 A JP2009513529 A JP 2009513529A JP 2006518169 A JP2006518169 A JP 2006518169A JP 2006518169 A JP2006518169 A JP 2006518169A JP 2009513529 A JP2009513529 A JP 2009513529A
Authority
JP
Japan
Prior art keywords
active ingredient
carrier
substance
magnesium stearate
solid pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006518169A
Other languages
English (en)
Japanese (ja)
Inventor
モンティス，マイケル，ジョン
トーマス，マリアン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0316341.7A external-priority patent/GB0316341D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of JP2009513529A publication Critical patent/JP2009513529A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
JP2006518169A 2003-07-11 2004-07-08 ステアリン酸マグネシウムを含む医薬製剤 Pending JP2009513529A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB0316341.7A GB0316341D0 (en) 2003-07-11 2003-07-11 Pharmaceutical formulations
GB0316341.7 2003-07-11
US50541503P 2003-09-23 2003-09-23
US60/505,415 2003-09-23
PCT/EP2004/007666 WO2005004845A1 (en) 2003-07-11 2004-07-08 Pharmaceutical formulations comprising magnesium stearate

Publications (1)

Publication Number Publication Date
JP2009513529A true JP2009513529A (ja) 2009-04-02

Family

ID=34066619

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006518169A Pending JP2009513529A (ja) 2003-07-11 2004-07-08 ステアリン酸マグネシウムを含む医薬製剤

Country Status (3)

Country Link
EP (1) EP1643973A1 (de)
JP (1) JP2009513529A (de)
WO (1) WO2005004845A1 (de)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013512270A (ja) * 2009-12-01 2013-04-11 グラクソ グループ リミテッド ムスカリン受容体拮抗薬およびβ２アドレナリン受容体作動薬の組み合わせ
JP2013525327A (ja) * 2010-04-21 2013-06-20 シエシー ファルマセウティチィ ソシエタ ペル アチオニ 帯電を低減した粒子を提供する方法
JP2015509973A (ja) * 2012-03-13 2015-04-02 レスピバート・リミテツド 結晶性ｐｉ３キナーゼ阻害剤
JP2019511556A (ja) * 2016-04-15 2019-04-25 チア タイ ティエンチン ファーマシューティカル グループ カンパニー リミテッドＣｈｉａ Ｔａｉ Ｔｉａｎｑｉｎｇ Ｐｈａｒｍａｃｅｕｔｉｃａｌ Ｇｒｏｕｐ Ｃｏ．， Ｌｔｄ． イソグリチルリチン酸またはその塩の吸入製剤および呼吸器疾患を治療する薬物の製造におけるそれらの応用

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003024396A2 (en) 2001-09-17 2003-03-27 Glaxo Group Limited Dry powder medicament formulations
CN102099030A (zh) * 2008-05-05 2011-06-15 罗切斯特大学 用于治疗或预防病理性心脏重构和心力衰竭的方法及组合物
EP2400950B1 (de) 2009-02-26 2019-05-22 Glaxo Group Limited Pharmazeutische formulierungen enthaltend 4-{(1 r)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol
KR101886987B1 (ko) 2010-09-30 2018-08-08 키에시 파르마슈티시 엣스. 피. 에이. 흡입용 건조 분말 제제 내 마그네슘 스테아레이트의 용도
EP2836204B1 (de) 2012-04-13 2020-07-08 GlaxoSmithKline Intellectual Property Development Limited Aggregatteilchen
GB201305825D0 (en) 2013-03-28 2013-05-15 Vectura Ltd New use

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001078694A2 (en) * 2000-04-17 2001-10-25 Vectura Limited Formulations for use in inhaler devices
WO2002000197A1 (en) * 2000-06-27 2002-01-03 Vectura Limited Method of making particles for use in a pharmaceutical composition
JP2002529498A (ja) * 1998-11-13 2002-09-10 ヤゴ・リサーチ・アクチェンゲゼルシャフト 吸入用の乾燥粉末

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1204826B (it) 1986-03-04 1989-03-10 Chiesi Farma Spa Composizioni farmaceutiche per inalazione
GB9001635D0 (en) 1990-01-24 1990-03-21 Ganderton David Aerosol carriers
DE4140689B4 (de) 1991-12-10 2007-11-22 Boehringer Ingelheim Kg Inhalationspulver und Verfahren zu ihrer Herstellung
GB9322014D0 (en) 1993-10-26 1993-12-15 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
EP0865302B1 (de) 1995-12-07 2000-05-31 Jago Pharma Ag Inhalator zur mehrfachen dosisweisen abgabe eines pharmakologischen trockenpulvers
GB0208608D0 (en) * 2002-04-13 2002-05-22 Glaxo Group Ltd Composition

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002529498A (ja) * 1998-11-13 2002-09-10 ヤゴ・リサーチ・アクチェンゲゼルシャフト 吸入用の乾燥粉末
WO2001078694A2 (en) * 2000-04-17 2001-10-25 Vectura Limited Formulations for use in inhaler devices
WO2002000197A1 (en) * 2000-06-27 2002-01-03 Vectura Limited Method of making particles for use in a pharmaceutical composition

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013512270A (ja) * 2009-12-01 2013-04-11 グラクソ グループ リミテッド ムスカリン受容体拮抗薬およびβ２アドレナリン受容体作動薬の組み合わせ
JP2013525327A (ja) * 2010-04-21 2013-06-20 シエシー ファルマセウティチィ ソシエタ ペル アチオニ 帯電を低減した粒子を提供する方法
JP2015509973A (ja) * 2012-03-13 2015-04-02 レスピバート・リミテツド 結晶性ｐｉ３キナーゼ阻害剤
JP2015509972A (ja) * 2012-03-13 2015-04-02 レスピバート・リミテツド 新規製薬学的製剤
US9642799B2 (en) 2012-03-13 2017-05-09 Respivert, Ltd. Crystalline 6-(2-((4-amino-3-(3-hydroxyphenyl)-1H-pyrazolo[3,4-D]pyrimidin-1-yl)methyl)-3-(2-chlorobenzyl)-4-0X0-3,4-dihydroquinazolin-5-yl)-N,N-bis(2-methoxyethyl)hex-5-ynamide
JP2018008992A (ja) * 2012-03-13 2018-01-18 レスピバート・リミテツド 結晶性ｐｉ３キナーゼ阻害剤
JP2019511556A (ja) * 2016-04-15 2019-04-25 チア タイ ティエンチン ファーマシューティカル グループ カンパニー リミテッドＣｈｉａ Ｔａｉ Ｔｉａｎｑｉｎｇ Ｐｈａｒｍａｃｅｕｔｉｃａｌ Ｇｒｏｕｐ Ｃｏ．， Ｌｔｄ． イソグリチルリチン酸またはその塩の吸入製剤および呼吸器疾患を治療する薬物の製造におけるそれらの応用
JP2021176903A (ja) * 2016-04-15 2021-11-11 チア タイ ティエンチン ファーマシューティカル グループ カンパニー リミテッドChia Tai Tianqing Pharmaceutical Group Co., Ltd. イソグリチルリチン酸またはその塩の吸入製剤および呼吸器疾患を治療する薬物の製造におけるそれらの応用
JP7166929B2 (ja) 2016-04-15 2022-11-08 チア タイ ティエンチン ファーマシューティカル グループ カンパニー リミテッド イソグリチルリチン酸またはその塩の吸入製剤および呼吸器疾患を治療する薬物の製造におけるそれらの使用
US11534398B2 (en) 2016-04-15 2022-12-27 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Inhaled preparation of isoglycyrrhizic acid or salt thereof, and use in preparing drugs for treating respiratory system diseases
JP7309791B2 (ja) 2016-04-15 2023-07-18 チア タイ ティエンチン ファーマシューティカル グループ カンパニー リミテッド イソグリチルリチン酸またはその塩の吸入製剤および呼吸器疾患を治療する薬物の製造におけるそれらの使用

Also Published As

Publication number Publication date
WO2005004845A1 (en) 2005-01-20
EP1643973A1 (de) 2006-04-12

Similar Documents

Publication Publication Date Title
US11090294B2 (en) Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist
US20100093866A1 (en) Pharmaceutical Formulations
US11116721B2 (en) Pharmaceutical formulations comprising 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl) phenol
US20050256149A1 (en) Pharmaceutical compositions containing tiotropium salts and low-solubility salmeterol salts
WO2001078745A1 (en) Medical combinations comprising formoterol and fluticasone proprionate
US20050232871A1 (en) Use of compounds in a dry powder inhaler
JP2009514779A (ja) 医薬製剤
ES2797073T3 (es) Partículas de inhalación que comprenden una combinación de un anticolinérgico, un corticoesteroide y un beta-adrenérgico
KR20180104197A (ko) 아베디테롤의 신규한 투약 형태 및 제형
JP2009513529A (ja) ステアリン酸マグネシウムを含む医薬製剤
US20060165785A1 (en) Method of chemically stabilizing pharmaceutical formulations with cholesterol
US20140116434A1 (en) Dry Powder Inhaler Compositions
EP2957552B1 (de) Vilanterolformulierungen
JP2009513531A (ja) 糖エステルを含む吸入可能医薬製剤
WO2001078744A1 (en) Medical combinations comprising formoterol and mometasone
EP2957553A1 (de) Pharmazeutische formulierungen von vilanterol
WO2006076222A2 (en) Pharmaceutical formulations
JP2004500432A (ja) モメタゾンとサルメテロールを含む組合せ医薬
WO2010097114A1 (en) Novel combination of therapeutic agents
WO2006066907A1 (en) Pharmaceutical formulations
US20060233716A1 (en) Pharmaceutical formulations
US20060210485A1 (en) Pharmaceutical formulations
ZA200406911B (en) Powder formulations suitable for inhalation
EP2957551B1 (de) Trockenpulverformulierungen mit vilanterol
JP2004500436A (ja) 呼吸器用組成物

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20101019

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20110113

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20110120

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20110628